Insmed director Sharoky sells $637,650 of Insmed stock

Melvin Sharoky, a Director of Insmed Inc (INSM), disposed of 5,000 shares of the company's stock on August 17, 2026. The shares were sold at prices between $127.51 and $127.61, generating a total sale value of $637,650. This insider sale of common stock by Dr. Sharoky occurred despite the company's analysts maintaining a strong buy consensus with price targets indicating a 56% potential upside.

Even after this transaction, Dr. Sharoky holds 246,081 shares directly and has indirect beneficial ownership of additional shares via various entities and accounts, including 6,847 shares held by his spouse and shares held as custodian for several individuals. Despite recent news highlighting Insmed's robust financial performance, with significant revenue increases from its lung-disease drugs BRINSUPRI and ARIKAYCE, leading to a raise in the company's full-year sales outlook for 2026, some analysts still perceive the stock as overvalued based on Fair Value estimates.